Upcoming catalysts and material SEC filings for TENAX THERAPEUTICS, INC. (TENX). 1 upcoming catalyst.
Trial readout (estimated) — TNX-103
Q3 2026 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 9d ago